Fred Hassan

Insider Reports History

Location
Boca Raton, FL
Signature
/s/ Fred Hassan, by Donald P. Lehr, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fred Hassan:

Form 4 holding Director

PRECIGEN, INC.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$0
Report date
13 Mar 2026
Price
$1.74
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

PRECIGEN, INC.

Security class
Option to Purchase Common Stock (Right to Buy)
Shares / value
41,073
Estimated value
Report date
10 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

EyePoint, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
40,000
Estimated value
Report date
02 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Cocrystal Pharma, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
16,410
Estimated value
Report date
09 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Prometheus Biosciences, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
16 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Fred Hassan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .